Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
- Resource Type
- Correction Notice
- Authors
- Teng, Fei; Zhang, Ju-Xiang; Chang, Qi-Meng; Wu, Xu-Bo; Tang, Wei-Guo; Wang, Jian-Fa; Feng, Jin-Feng; Zhang, Zi-Ping; Hu, Zhi-Qiu
- Source
- Journal of Experimental & Clinical Cancer Research (17569966). 12/9/2020, Vol. 39 Issue 1, p1-6. 6p.
- Subject
- *LINCRNA
*HEPATOCELLULAR carcinoma
*CANCER invasiveness
*NEOVASCULARIZATION
- Language
- ISSN
- 1756-9966
An amendment to this paper has been published and can be accessed via the original article. [ABSTRACT FROM AUTHOR]